Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to -$487000.0.

  • Anaptysbio's Other Working Capital Changes rose 6533.81% to -$487000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year increase of 6989.73%. This contributed to the annual value of -$3.2 million for FY2024, which is 17637.1% down from last year.
  • As of Q3 2025, Anaptysbio's Other Working Capital Changes stood at -$487000.0, which was up 6533.81% from -$414000.0 recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Other Working Capital Changes ranged from a high of $5.8 million in Q3 2023 and a low of -$6.7 million during Q4 2021
  • Moreover, its 5-year median value for Other Working Capital Changes was -$391000.0 (2023), whereas its average is -$7578.9.
  • Per our database at Business Quant, Anaptysbio's Other Working Capital Changes skyrocketed by 113090.13% in 2021 and then tumbled by 28780.64% in 2024.
  • Over the past 5 years, Anaptysbio's Other Working Capital Changes (Quarter) stood at -$6.7 million in 2021, then skyrocketed by 40.31% to -$4.0 million in 2022, then rose by 29.33% to -$2.8 million in 2023, then surged by 89.48% to -$299000.0 in 2024, then plummeted by 62.88% to -$487000.0 in 2025.
  • Its Other Working Capital Changes was -$487000.0 in Q3 2025, compared to -$414000.0 in Q2 2025 and -$530000.0 in Q1 2025.